Classical rather than genetic risk factors account for high cardiovascular disease prevalence in Lithuania: A

Neringa Burokienė1, Ingrida Domarkienė2, Laima Ambrozaitytė2

  • 1Clinics of Internal Diseases, Family Medicine and Oncology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Insights

High BMI and poor lipid profiles are key drivers of cardiovascular disease (CVD) mortality in Lithuania. Lifestyle factors and genetics do not fully explain elevated CVD rates, necessitating a focus on weight and cholesterol management for prevention.

Area of Science:

  • Cardiology and Public Health
  • Epidemiology
  • Genetics

Background:

  • Cardiovascular disease (CVD) mortality is disproportionately high in Lithuania, representing 54% of all deaths, the highest rate in the EU.
  • Understanding the specific risk factors contributing to this elevated CVD prevalence is crucial for targeted public health interventions.

Purpose of the Study:

  • To investigate the prevalence of CVD risk factors in the Lithuanian population, including lifestyle, biochemical markers, and genetic predispositions.
  • To identify the primary reasons for the significantly increased CVD prevalence and mortality in Lithuania compared to other European populations.

Main Methods:

  • A study involving 435 Lithuanian volunteers with multi-generational geographic stability.
  • Measurement of anthropometric, biochemical, and behavioral risk factors; genotyping of 60 CVD risk alleles in a subset of 166 volunteers.
  • Comparison of genetic risk scores with the North-West European (CEU) population using HapMap phase 3 data.

Main Results:

  • CVD was prevalent in 33.8% of participants, with high rates of alcohol consumption (84%), smoking (21%), and low physical activity (30%).
  • Average Body Mass Index (BMI), total cholesterol, and LDL-cholesterol levels were elevated above normal ranges in both males and females.
  • Lithuanians showed only a 1.4% higher cumulative genetic susceptibility to CVD compared to the CEU population.

Conclusions:

  • Elevated BMI and unfavorable plasma lipid profiles are identified as the principal contributors to high CVD mortality and morbidity in Lithuania.
  • Smoking, alcohol consumption, and genetic predisposition do not sufficiently explain the disparity in CVD mortality between Lithuania and other European populations.
  • Future CVD prevention programs in Lithuania should prioritize strategies for weight reduction and improved blood lipid management.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
631
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
538
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
786
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1000